AvePoint, Inc. Class A AVPT 深 滬
已收盤 06-18 16:00:00 美东时间
10.41
-0.340
-3.16%
華盛通- 最 高10.75
- 今 開10.75
- 成交量 362.46万股
- 最 低 9.995
- 昨 收 10.75
- 總市值 22.07亿
- 52周最高 19.95
- 市盈率 靜 68.58
- 換手率 1.71%
- 52周最低 8.835
- 委 比 -68.57%
- 總股本 2.12亿
- 歷史最高 20.245
- 量 比 1.20
- 振 幅 7.02%
- 歷史最低 3.40
- 每 手 1
- 風險率 2.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Scotiabank Maintains Sector Outperform on AvePoint, Lowers Price Target to $12
Scotiabank analyst Joe Vandrick maintains AvePoint (NASDAQ:AVPT) with a Sector Outperform and lowers the price target from $13 to $12.
05-09 04:49
AvePoint shares are trading higher after the company reported better-than-expected Q1 financial results.
AvePoint shares are trading higher after the company reported better-than-expec...
05-08 23:32
财报速睇 | AvePoint, Inc. Class A 2026财年Q1营收1.17亿美元，同比增长26.0%；归母净利润0.15亿美元，同比增长343.3%
华盛资讯5月8日讯，AvePoint, Inc. Class A公布2026财年Q1业绩，公司Q1营收1.17亿美元，同比增长26.0%，归母净利润0.15亿美元，同比增长343.3%。
05-08 09:00
财报速睇 | AvePoint, Inc. Class A 2026财年Q1营收1.17亿美元，同比增长26.0%；归母净利润0.15亿美元，同比增长343.3%
华盛资讯5月8日讯，AvePoint, Inc. Class A公布2026财年Q1业绩，公司Q1营收1.17亿美元，同比增长26.0%，归母净利润0.15亿美元，同比增长343.3%。
05-08 06:25
Shares of companies in the broader software sector are trading lower amid a pullback in sentiment after Q1 financial results and outlook comments from industry peers IBM and ServiceNow.
Shares of companies in the broader software sector are trading lower amid a pul...
04-24 02:46
William Blair Downgrades AvePoint to Market Perform
William Blair analyst Jason Ader downgrades AvePoint (NASDAQ:AVPT) from Outperform to Market Perform.
03-23 21:02
美股大行评级 | 花旗：维持康菲石油"买入"评级！目标价从125美元升至135美元
今日重点评级关注：HC Wainwright & Co.：维持Helus Pharma"买入"评级，目标价从55美元升至95美元；HC Wainwright & Co.：维持Compass Pathways"买入"评级，目标价从40美元升至70美元
03-03 20:22
美股大行评级 | 下调居多！多邻国、Elastic、Flutter、欧特克、Zscaler等遭多家机构下调目标价
今日重点评级关注：巴克莱：维持C4 Therapeutics"超配"评级，目标价从5美元升至7美元；富国银行：维持Agilon Health"超配"评级，目标价从1美元升至1.5美元
03-02 14:08
Evercore ISI Group Maintains Outperform on AvePoint, Lowers Price Target to $14
Evercore ISI Group analyst Kirk Materne maintains AvePoint (NASDAQ:AVPT) with a Outperform and lowers the price target from $18 to $14.
02-27 21:41
